Agilent Technologies Inc. (NYSE:A) urged a California federal judge on Thursday to toss Genetic Technologies Ltd.’s lawsuit accusing Agilent of selling a DNA-testing device that infringes GT’s patent on genetic analysis technology, arguing that GT’s patent is invalid because it’s based on an unpatentable natural phenomenon. Agilent Technologies Inc. (NYSE:A) stock opened at $59.06 in last session, and closed at $58.42, while the day range of stock is $57.52 – $59.20. The stock showed a positive weekly performance of 2.62%.
Organovo Holdings Inc (NYSEMKT:ONVO) is using 3-D printers to create living tissue that might one day look and act like a human liver, cleansing the body of toxins. Drugmakers and cosmetics companies already plan to use 3-D printed human tissue to test new products. Organovo Holdings Inc (NYSEMKT:ONVO) stock opened at $9.90, in last session and closed at $9.70, by losing -2.02%. The 52 week range of the stock is $3.27 – $13.65. Company’s market capitalization is $754.82 million.
Intrinsic Bioprobes was purchased by Thermo Fisher Scientific Inc. (NYSE:TMO) in 2011 and Nelson and Nedelkov continue to collaborate with the company on MSIA-based protein biomarker assays. Thermo Fisher Scientific Inc. (NYSE:TMO) stock advanced 0.21% and finished the last session at $126.67. The EPS of the stock remained 3.50. Company’s market capitalization is $49.63 billion.
Quest Diagnostics, Inc (NYSE:DGX) which has about 2,200 patient service centers and laboratories in most major metropolitan centers, reported in November a 74 percent decline in drug use among American workers during the past 25 years in an analysis of more than 125 million workplace urine drug tests. Quest Diagnostics Inc (NYSE:DGX) stock opened the session at $52.66, and closed the session at $52.58. The 52 week range of the stock remained $50.46 – $64.10 and the day range was $52.53 – $53.02.